Highlights Zynex, Inc.

Equities

ZYXI

US98986M1036

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-21 pm EDT			5-day change	1st Jan Change
10.58 ^USD	+0.19%		-2.58%	-2.85%

Apr. 30	Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on February 29, 2024.	CI
Apr. 30	Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on November 1, 2023.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on February 29, 2024.	Apr. 30	CI
Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on November 1, 2023.	Apr. 30	CI
Earnings Flash (ZYXI) ZYNEX Posts Q1 Revenue $46.5M, vs. Street Est of $47.7M	Apr. 30	MT
Zynex, Inc. Provides Earnings Guidance for the Second Quarter of 2024 and Reaffirms for the Full Year 2024	Apr. 30	CI
Zynex, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 30	CI
Zynex, Inc.'s Equity Buyback announced on November 1, 2023, has closed with 1,900,020 shares, representing 5.64% for $20 million.	Mar. 30	CI
Zynex, Inc. Provides Earnings Guidance First Quarter and Full Year 2024	Feb. 29	CI
Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on September 11, 2023.	Feb. 29	CI
Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on November 1, 2023.	Feb. 29	CI
Zynex, Inc. announces an Equity Buyback for $20 million worth of its shares.	Feb. 29	CI
Earnings Flash (ZYXI) ZYNEX Reports Q4 Revenue $47.3M, vs. Street Est of $55.6M	Feb. 29	MT
Zynex, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 29	CI
Zynex, Inc. authorizes a Buyback Plan.	Feb. 28	CI
Zynex, Inc. Introduces New Products	Feb. 20	CI
Zynex Receives US FDA Approval for Muscle Stimulation Device	Feb. 06	MT
Zynex, Inc. Receives FDA Clearance for its Next Generation NMES Device	Feb. 06	CI
Zynex, Inc.'s Equity Buyback announced on September 11, 2023, has closed with 1,204,239 shares, representing 3.43% for $10 million.	Dec. 30	CI
Zynex, Inc. Submits FDA Application for Its NMES Device	Nov. 13	CI
Zynex to Repurchase Up to $20 Million Common Shares Through Nov. 1, 2024	Nov. 01	MT
Zynex, Inc. announces an Equity Buyback for $20 million worth of its shares.	Nov. 01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Zynex, Inc.

Equities

ZYXI

US98986M1036

Highlights

Filters